ILDong: Ildong Pharmaceutical to refile approval application for oral Covid-19 treatment

Ildong Pharmaceutical announced plans to reapply for marketing authorization of the oral antiviral Covid-19 treatment, Ensitrelvir fumaric acid, after strengthening its clinical data.The company aims to incorporate findings from the recently completed global clinical trial, SCORPIO-PEP, which evalua